Skip to main content
. 2013 Jul 8;591(Pt 18):4549–4565. doi: 10.1113/jphysiol.2013.258681

Figure 4. Influence of the cyclic guanosine monophosphate-dependent protein kinase inhibitor Rp-8-Br-PET-cGMPS (10–50 μm) on the active lymph pump in rat thoracic duct at different levels of imposed flow pressure gradients (inlet pressure > outlet pressure).

Figure 4

*Significant differences (P < 0.05) between control and Rp-8-Br-PET-cGMPS treatment within each level of imposed flow pressure gradients. Rp-8-Br-PET-cGMPS, guanosine 3′,5′-cyclic monophosphorothioate, 8-(4-Chlorophenylthio)-, Rp-isomer, triethylammonium salt.